Table 2.

Genetic mutations at diagnosis for survival outcomes.

Genetic mutation	UnivariateP value; HR (95%CI)		Multivariable P value; HR (95%CI)
	Overall Survival	Progression-Free Survival	Progression-Free Survival
ASXL1	0.768; 0.847 (0.281-2.554)	0.783; 1.113 (0.519-2.388)	–
DNMT3A	0.180; 2.131 (0.705-6.438)	0.052; 2.291 (0.993-5.289)	0.041; 2.399 (1.035-5.563)
NPM1	0.165; 2.398 (0.673-8.244)	0.291; 1.758 (0.617-5.004)	–
TET2	0.387; 0.043 (0.00-53.161)	0.241; 0.304 (0.042-2.226)	–
U2AF1	0.341; 0.585 (0.194-1.764)	0.252; 0.629 (0.284-1.390)	–
NRAS	0.366; 0.043 (0.00-39.903)	0.235; 0.043 (0.00-7.824)	–
RUNX1	0.202; 0.269 (0.036-2.017)	0.706; 0.833 (0.233-2.155)	–
ETV6	0.402; 0.044 (0.00-66.889)	0.784; 1.181 (0.360-3.878)	–
TP53	0.034; 3.836 (1.109-13.269)	0.011; 3.946 (1.369-11.374)	0.008; 4.180 (1.441-12.122)